Structure–activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction

European Journal of Medicinal Chemistry
2012.0

Abstract

This paper describes the synthesis of nine selected diaryl/heteroaryl-containing phenol and polyphenol derivatives which have been evaluated against Bax/Bcl-xL interaction in comparison with ABT-737. Using a BRET assay, six of these derivatives exhibit activity comparable to ABT-737 to disrupt Bax/Bcl-xL interaction. These preliminary results demonstrate that such polyphenol-derived molecules are attractive compounds regarding anticancer activity and that the phenol at position 3 is important regarding disruption of Bax/Bcl-xL interaction.

Knowledge Graph

Similar Paper

Structure–activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction
European Journal of Medicinal Chemistry 2012.0
Structure−Activity Relationship Studies of Phenanthridine-Based Bcl-X<sub>L</sub> Inhibitors
Journal of Medicinal Chemistry 2008.0
Synthesis and biological activities of polyquinoline derivatives: New Bcl-2 family protein modulators
European Journal of Medicinal Chemistry 2012.0
Perturbing pro-survival proteins using quinoxaline derivatives: A structure–activity relationship study
Bioorganic &amp; Medicinal Chemistry 2012.0
Synthesis and structure–activity relationships of 5-phenyloxazole-2-carboxylic acid derivatives as novel inhibitors of tubulin polymerization
Bioorganic &amp; Medicinal Chemistry Letters 2021.0
A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors
Bioorganic &amp; Medicinal Chemistry 2015.0
Synthesis and biological activities of new di- and trimeric quinoline derivatives
Bioorganic &amp; Medicinal Chemistry 2010.0
Synthesis of natural product-like polyprenylated phenols and quinones: Evaluation of their neuroprotective activities
Bioorganic &amp; Medicinal Chemistry 2020.0
Structure-Based Discovery of BM-957 as a Potent Small-Molecule Inhibitor of Bcl-2 and Bcl-xL Capable of Achieving Complete Tumor Regression
Journal of Medicinal Chemistry 2012.0
Synthesis and antitumor activity of novel 3-oxo-23-hydroxybetulinic acid derivatives
European Journal of Medicinal Chemistry 2014.0